Testing effectiveness (Phase 2)Study completedNCT02648581
What this trial is testing
Efficacy and Safety of Ustekinumab, a Human Monoclonal Anti-IL-12/IL-23 Antibody, in Patients With Behçet Disease
Who this might be right for
Behçet Disease
Assistance Publique - Hôpitaux de Paris 16